Guido Silvestri, MD, named Executive Associate Dean of Research Strategy for the School of Medicine
MAY 20, 2022
Dean of Emory University School of Medicine, Vikas Sukhatme, recently announced the appointment of Guido Silvestri, MD, Professor and Chair, Department of Pathology and Laboratory Medicine, to the role of Executive Associate Dean of Research Strategy in the School of Medicine. Concurrently, Dr. Silvestri will maintain his role as Chair of the Department of Pathology & Laboratory Medicine. Dr. Silvestri is also an Eminent Scholar in Comparative AIDS Research, Georgia Research Alliance, and Chief of the Division of Microbiology and Immunology at the Emory National Primate Research Center.
In this role, working with dean’s office leadership and researchers across the SOM, Dr. Silvestri will support and guide realization of the SOM Excellence to Eminence strategic research vision. This will include work to determine strategic opportunities, assess measurements of return on investment for research support and consideration of innovative models for advancing research.
Dr. Silvestri received his M.D. from the University of Ancona (Italy) in 1987, and after finishing his service in the Italian Navy, he completed his training in Internal Medicine/ Allergology & Clinical Immunology in 1993. Soon after, he moved to North America and became involved in basic and translational research studies of AIDS pathogenesis, prevention, and therapy, mostly using non-human primate models of HIV infection. In 2001, Dr. Silvestri received a Board Certification in Clinical Pathology upon completion of a residency at the Hospital of the University of Pennsylvania.
Since 2001, Dr. Silvestri has directed an independent NIH-funded research program. He is currently the principal investigator or a co-investigator of sixteen NIH grants, including a prestigious R37 MERIT award, and he is involved in both the Consortium for Innovative AIDS Research (CIAR) in non-human primates, the Center for HIV/AIDS Vaccine Immunology (CHAVI), and the Collaboratory of AIDS Researchers for Eradication (CARE). He is currently co-director of the Emory-based Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE HIV), which was recently awarded a 5-year $25M grant from the NIH.
Dr. Silvestri has authored or co-authored 279 peer-reviewed publications, many in high impact journals including Nature, Cell, Science, and Nature Medicine. He has given invited lectures and seminars at more than 120 different institutions of 28 different countries. His work has been quoted more than 28,000 times (H-index 82) and has been presented in plenary sessions at all major virology and immunology conferences worldwide. Dr. Silvestri is Editor of the Journal of Virology, Associate Editor of PLoS Pathogens, and past Editor of the Journal of Immunology.
Dr. Silvestri served as Chairman or Standing Member in more than 50 study sections and advisory committees at the National Institutes of Health, the Canadian Institute for Health Research, the American Foundation for AIDS Research, the Australian Medical Research Council, the European Commission, and various other institutions. In 2022 he received the prestigious Dr. Martin Luther King Jr. Community Service Award of Emory University, and the Fiuggi Storia-Scienze award of the Levi-Pelloni Foundation and the Library of Shoah.